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Interleukin-4 deficiency enhances Th1 responses and crescentic glo-
merulonephritis in mice. Evidence suggests that crescentic glomerulone-
phritis (GN) is due to T helper cell 1 (Th1) directed delayed-type
hypersensitivity (DTH)-like injury. As endogenous interleukin (IL)-4, (the
pivotal cytokine in Th2 responses) may attenuate Th1 responses in this
disease, we compared the development of crescentic GN, induced by a
planted antigen, in mice genetically deficient in IL-4 (IL-42/2) with
disease in normal mice (IL-41/1). IL-42/2 mice developed more severe
GN with increased renal impairment (CCr 35 6 7 ml/min vs. 133 6 14
ml/min, P , 0.002) and crescent formation (55.7 6 8.4% vs. 4.9 6 1.2%,
P , 0.002). This was associated with increased glomerular fibrin deposi-
tion, glomerular CD41 T cell infiltration and macrophage recruitment.
Systemically, IL-42/2 mice showed an increased antigen specific Th1
response indicated by increased skin DTH, and increased IgG3 and
IgG2b. Decreased IgG1 levels indicated a reduced Th2 response. These
results demonstrate a protective role for endogenous IL-4 in crescentic
GN. They show that IL-4 deficiency promotes crescentic glomerular injury
and amplifies local and systemic Th1 responses. They support the hypoth-
esis that crescent formation results from Th1 immune responses to
antigens in the glomerulus.
The formation of glomerular crescents, which occurs in the
setting of proliferative forms of glomerulonephritis (GN), indi-
cates severe disease and is associated with a poor clinical out-
come. Important immunopathological events in crescentic GN
include recruitment of CD41 T cells and macrophages and
prominent glomerular deposition of fibrin, akin to a T helper cell
1 (Th1) directed, delayed-type hypersensitivity (DTH)-like re-
sponse. These features have been demonstrated in both human
crescentic GN [1, 2] and animal models of crescentic GN [3, 4].
Delayed-type hypersensitivity is mediated by the Th1 subset of
CD41 T cells, which characteristically produce IFN-g and IL-2 [5,
6]. T helper cell 2 (Th2) CD41 T cells produce IL-4 and IL-10,
which tend to inhibit macrophage functions and stimulate pro-
duction of IgE and IgG1 [7]. The cytokine profile of antigen
stimulated T cells depends on the cytokine milieu at the time of
antigen presentation [8], with IL-12 being important in the
differentiation of T cells into Th1 cells [9] and IL-4 being crucial
to Th2 responses [10]. The concept of Th1 and Th2 responses has
been modified to suggest that, while an immune response to a
specific antigen may be characterized as predominantly Th1 or
Th2 mediated, antigen-specific T cells produce a spectrum of
cytokines with pure Th1 and Th2 cytokine secretors being at the
two extremes of a spectrum [11].
The hypothesis that endogenous IL-4 serves to direct immuno-
logical responses toward Th2, while limiting Th1 responses and
thus attenuating crescentic GN, was addressed using mice with a
targeted disruption of the IL-4 gene [12]. These mice have been
characterized to be deficient in IL-4, and to possess a relative
deficiency in the acquisition of antigen-specific Th2 responses
[12]. Glomerulonephritis was initiated in mice previously sensi-
tized to sheep globulin (SG) by planting this antigen on the
glomerular basement membrane (GBM) using a sheep anti-
mouse GBM antibody. The development of the systemic and local
immune response to this antigen and the subsequent glomerular
injury were compared in the presence and absence of endogenous
IL-4.
METHODS
Animals and induction of anti-glomerular basement membrane
glomerulonephritis
Interleukin-42/2 and IL-41/1 mice, previously characterized
[12], on a mixed background of C57BL/6 and 129Sv were a
generous gift of Dr. Manfred Kopf. Mice were bred at Monash
University Animal Services (Melbourne, Australia). Anti-glomer-
ular basement membrane globulin was prepared as previously
described [13]. Eight- to ten-week-old male mice were sensitized
by s.c. injection of a total of 2 mg of sheep globulin in 200 ml of
CFA (Sigma Chemical Co., St. Louis, MO, USA) in divided doses
in each flank. After 10 days, GN was initiated by i.v. administra-
tion of 9.5 mg of sheep anti-mouse GBM globulin.
Histological assessment of glomerular injury
Glomerular crescent formation. Kidney tissue was fixed in
Bouin’s fixative, embedded in paraffin and 3 mm tissue sections
were cut and stained with periodic acid-Schiff reagent. Sections
from some animals’ kidneys were stained with silver methena-
mine/acid fuchsin. Glomerular crescent formation was assessed in
a blinded protocol. Glomeruli were considered to exhibit crescent
formation when three or more layers of cells were observed in
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Bowman’s space. A minimum of 50 glomeruli were assessed to
determine the percentage of glomeruli affected in each animal.
Assessment of glomerular deposition of sheep globulin, mouse
immunoglobulin, immunoglobulin isotypes and fibrin. Tissue was
embedded in Optimal Cutting Temperature Compound (OCT;
Miles Scientific, IN, USA), immediately frozen in liquid nitrogen
and stored at 270°C. Immunofluorescence was performed on 4
mm cryostat cut tissue sections and results assessed in a blinded
protocol. Glomerular deposition of sheep globulin was evaluated
using FITC conjugated donkey anti-sheep immunoglobulin (Sile-
nus, Hawthorn, Victoria, Australia). Serial dilutions of this anti-
body were made to determine the end point positive titer for
glomerular sheep globulin. Deposition of total mouse immuno-
globulin was detected using FITC conjugated sheep anti-mouse
immunoglobulin (dilution 1 in 500; Silenus). Glomerular deposi-
tion of immunoglobulin isotopes was assessed using either mono-
clonal rat anti-mouse IgG1, IgG2a, IgG2b or IgG3 (dilution 1 in
100; Pharmingen, San Diego, CA, USA) as the primary antibody
followed by FITC conjugated sheep anti-rat immunoglobulin (1 in
100; Silenus) absorbed against normal mouse serum. Omission of
the primary antibody served as a negative control. Fluorescence
intensity was scored semiquantitatively (0 to 31). Glomerular
fibrin deposition was detected on a minimum of 30 glomeruli per
mouse using FITC conjugated goat anti-mouse fibrin/fibrinogen
serum (Nordic Immunological Laboratories, Berks, UK) at a
dilution of 1 in 25, and scored semiquantitatively (0 to 31) as
follows: 0 5 no fibrin deposition, 1 5 fibrin occupying up to one
third of the glomerular cross-sectional area, 2 5 fibrin occupying
one third to two thirds of the glomerulus, 3 5 greater than two
thirds of the glomerular cross-section covered by fibrin.
Glomerular T cell and macrophage accumulation. Spleen and
kidney tissue was fixed in periodate/lysine/paraformaldehyde for
four hours, washed in 7% sucrose solution, then frozen in liquid
nitrogen. Tissue sections (6 mm thick) were stained to demon-
strate macrophages and CD41 T cells using a three-layer immu-
noperoxidase technique, as previously described [3, 14]. The
primary antibodies were GK1.5 [monoclonal anti-mouse CD4;
American Type Culture Collection (ATCC), Rockville, MD,
USA] and M1/70 (monoclonal anti-mouse Mac-1; ATCC). Sec-
tions of spleen provided positive controls and protein G purified
rat immunoglobulin was substituted for the primary monoclonal
antibody to provide a negative control. Glomeruli from non-
diseased IL-42/2 (N 5 5) and IL-41/1 mice (N 5 5) were
assessed to provide baseline values for glomerular T cell and
macrophage numbers. A minimum of 20 equatorially sectioned
glomeruli were assessed per animal. Results were expressed as
cells per glomerular cross section (c/gcs).
Functional assessment of glomerular injury
Creatinine clearance. Serum and urine creatinine concentrations
were measured by the alkaline picric acid method using an
autoanalyzer (Cobas Bio; Roche Diagnostic, Basel, Switzerland).
Creatinine clearance was calculated from the serum and urine
creatinine values and the urine volume.
Proteinuria. Twenty-four hour urine collections from each
mouse were made at three time points: prior to disease, from days
1 to 2 of disease, and over the final 24 hours of each experiment.
Urinary protein concentrations were determined by a modified
Bradford method [15], adapted to a microtiter plate assay as
previously described [3]. The 24-hour urinary protein excretion
was calculated from the 24-hour urine volume and the urinary
protein concentration.
Assessment of the systemic immune response to sheep globulin
Delayed-type hypersensitivity to sheep globulin. Mice were chal-
lenged 24 hours prior to the end of each experiment by intrader-
mal injection of SG (50 mg in 30 ml of PBS) into the plantar
surface of a hindfoot. An irrelevant antigen (horse globulin) was
injected in the opposite foot pad as a control. Delayed-type
hypersensitivity was quantified 24 hours later in a blinded protocol
by inspecting the footpads and measuring the difference in
thickness between SG and horse globulin injected footpads in
each mouse using a micrometer (Mitutoyo Corporation, Japan).
Results are expressed as the change in footpad thickness (mm)
between the horse globulin and the sheep globulin-injected sides.
Measurement of interferon (IFN)-g production by splenic T cells.
Spleens from sensitized mice were removed aseptically and placed
in RPMI 1640 5% FCS medium. Single cell suspensions were
prepared by gently teasing tissue apart. Erythrocytes were lysed by
incubation in Boyle’s solution (0.17 M Tris, 0.16 M ammonium
chloride) for one minute at 37°C. Cell suspensions were washed in
RPMI 1640 5% FCS, then enriched for T cells by passage through
nylon wool columns. Samples of enriched T cells (4 3 106 cells/ml
in RPMI 1640 10% FCS) were incubated for 72 hours at 37°C, 5%
CO2 in 48-well tissue culture plates with sheep IgG at a concen-
tration of 10 mg/ml. Interferon-g in culture supernatants was
measured by ELISA using flat bottom polystyrene microtiter
plates (Greiner Labortechnik, Kremsmu¨nster, Austria) coated
with rat anti-mouse IFN-g monoclonal antibody (RA-6A2;
Pharmingen,) at 5 mg/ml and blocked with 1% BSA. Supernatant
(100 ml) or recombinant murine IFN-g (Genzyme, Cambridge,
MA, USA) were incubated in wells overnight at 4°C. Biotinylated
rat anti-mouse IFN-g mAb (XMG1.2; Pharmingen) was used as
the detecting antibody at a concentration of 1 mg/ml. Plates were
washed and incubated with streptavidin horseradish peroxidase
complex (Silenus) at a dilution of 1 in 2000, washed then
incubated with ABTS (0.1 M 2,29-azino-di-3-ethylbenzthiazoline
sulfonate; Boehringer Mannheim, Germany) in 0.02% H2O2. The
absorbance at 405 nm was read on a microtiter plate reader
(Dynatech Laboratories, Chantilly, VA, USA). The lower limit for
detection of IFN-g in this assay was 6 pg/ml.
Measurement of circulating anti-sheep globulin IgG isotypes.
Isotypes of mouse anti-SG antibodies were measured by ELISA.
Plates were coated with 10 mg/ml SG in carbonate/bicarbonate
buffer (pH 9.6) by incubation overnight at 4°C and blocked with
1% BSA. Plates were washed, then incubated with mouse sera at
a dilution of 1 in 200. After further washing, binding of specific
mouse immunoglobulin isotypes was detected using horseradish
peroxidase conjugated goat anti-mouse IgG1, IgG2a, IgG2b and
IgG3 antibodies (Southern Biotechnology Assoc., Birmingham,
AL, USA) at a dilution of 1 in 4000. ABTS substrate solution was
added, the absorbance was read at 405 nm and the concentration
of each isotype between treatment groups was compared. Serum
from seven non-immunized mice (IL-41/1, N 5 3, IL-42/2, N 5
4) was tested as normal controls.
Experimental design and statistical analysis
Anti-glomerular basement membrane GN was induced as de-
scribed above and glomerular injury was assessed 10 days after
administration of anti-GBM globulin in IL-42/2 mice (N 5 6)
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and IL-41/1 mice (N 5 9). Measurements of proteinuria, renal
function, crescent formation and serum IgG isotypes were made
on six IL-42/2 mice and nine IL-41/1 mice, while assessments of
glomerular fibrin deposition, glomerular T cell and macrophage
numbers, glomerular immunofluorescence, footpad DTH and
splenic T cell IFN-g levels were performed on four IL-42/2 mice
and five IL-41/1 mice. Age matched, non-diseased, male IL-
42/2 (N 5 3 to 5) and IL-41/1 (N 5 4 to 5) mice were used for
baseline measurements. Results are expressed as the mean 6 SEM.
The statistical significance of differences between groups was
determined by the Mann Whitney U test.
RESULTS
Interleukin-4 deficient mice develop more severe crescentic
glomerulonephritis, with increased glomerular effectors of
delayed-type hypersensitivity
Kidneys of non-diseased IL-42/2 and IL-41/1 mice were
histologically normal. Glomerular CD41 T cells (IL-42/2
0.006 6 0.006 c/gcs, IL-41/1 0.04 6 0.02 c/gcs) and macrophages
(IL-42/2 0.04 6 0.02 c/gcs, IL-41/1 0.04 6 0.02 c/gcs) were
detected only rarely. Ten days after initiation of GN, IL-41/1
mice developed a diffuse proliferative GN (Fig. 1 A, C), with
glomerular T cell and macrophage infiltration (Fig. 1 E, G),
glomerular fibrin deposition and occasional crescent formation.
IL-42/2 mice developed considerably more severe GN than
IL-41/1 mice (Fig. 1 B, D). There was increased glomerular
crescent formation (55.7 6 8.4% vs. 4.9 6 1.2% P , 0.002; Figs.
1B and 2) and fibrin deposition (P , 0.02; Fig. 2). Glomerular
CD41 T cell and macrophage recruitment was significantly
enhanced in nephritic IL-42/2 mice (Fig. 1 F, H, and Fig. 2)
compared to IL-41/1 mice with GN. There was more than a
doubling of glomerular T cells (P , 0.02; Fig. 1F), and a
fourfold increase in glomerular macrophage numbers (P ,
0.02; Fig. 1H). Macrophages were observed in both the glo-
merular tuft and crescent, as well as in the periglomerular
region (Fig. 1H).
Glomerular deposition of sheep globulin and autologous
antibody
Glomeruli of mice with GN were stained by immunofluores-
cence for the nephritogenic antigen (sheep globulin), for total
mouse immunoglobulin and for IgG isotypes. Linear deposition of
both sheep and mouse globulin was observed in glomeruli. There
was no difference in the glomerular deposition of sheep globulin
or total mouse immunoglobulin between IL-41/1 and IL-42/2
mice. However, changes in fluorescence intensity of immunoglob-
ulin isotypes were observed, the results of which are presented in
Table 1. Deposition of IgG1 was decreased in IL-4 deficient mice
with GN, while deposition of IgG2b and IgG3 were increased
compared to IL-41/1 animals. Glomerular IgG2a was un-
changed. These semiquantitative assessments paralleled the quan-
titation of serum sheep globulin specific immunoglobulin isotypes
measured by ELISA and presented in Table 2.
Interleukin-4 deficient mice develop more severe functional
injury in crescentic glomerulonephritis
The IL-41/1 mice developed functional evidence of renal
injury with proteinuria (Fig. 3 and reduced creatinine clearance
(normal mice CCr 193 6 10 mL/min, IL-41/1 with GN 133 6 14
ml/min, P , 0.02, Fig. 4). However, IL-42/2 mice developed
more marked renal impairment than IL-41/1 mice (35 6 7
ml/min, P , 0.002), with severe renal failure (CCr less than 20% of
normal). Both IL-42/2 and IL-41/1 mice developed protein-
uria, with more severe proteinuria in IL-42/2 mice in the early
stages of disease (days 1 to 2, P 5 0.05; Fig. 3). This increase
became less statistically significant as renal impairment in IL-
42/2 mice became more severe (days 9 to 10, P 5 0.157).
Systemic immune responses of interleukin-4 deficient mice to
sheep globulin are more polarized towards a Th1 response
Both IL-42/2 and IL-41/1 mice developed cutaneous DTH
when challenged intradermally with SG injected 24 hours prior to
the end of the experiment. However, antigen-specific DTH re-
sponses were significantly greater in IL-4 deficient mice (P , 0.03;
Fig. 5). To further examine the nature of the T cell response to
SG, IFN-g production from splenic T cells of mice with GN was
measured. Interferon-g production was increased in IL-42/2
mice compared to IL-41/1 mice, but the increase did not reach
statistical significance (P 5 0.096; Fig. 5).
There were significant differences in antigen-specific immuno-
globulin isotypes between IL-41/1 and IL-42/2, indicating the
immune response to SG was further polarized towards a Th1
response in IL-42/2 mice (Table 2). There was a significant
reduction in antigen specific IgG1 (P , 0.002) in IL-42/2 mice,
and an increase in IgG3 (P , 0.002) and IgG2b (P , 0.002) levels.
Levels of IgG2a were unchanged.
DISCUSSION
Crescentic glomerulonephritis has immunopathological fea-
tures of a Th1 dependent, DTH response. Evidence to support
this view includes the presence of the effectors of DTH (T cells,
macrophages, tissue factor and fibrin) in glomeruli of humans with
crescentic GN [1] and the fact that many cases of human
crescentic GN occur in the absence of significant glomerular
deposition of antibody [16]. Studies in experimental crescentic
GN have allowed this hypothesis to be specifically tested. Crescent
formation occurs despite the absence of autologous antibody [17,
18] and can be prevented by T cell depletion [3, 4].
It has been recently shown in a planted antigen model of
crescentic GN similar to the one used in this study that the type of
renal injury depends on the balance between Th1 and Th2
cytokine production [4]. Th1 prone mice, C57BL/6, develop
crescent formation, glomerular T cells, macrophages and fibrin,
skin DTH to the nephritogenic antigen and higher levels of
splenic T cell IFN-g production relative to IL-4 production.
Antibody blockade of IFN-g [4] or administration of IL-4 and
IL-10 [19] attenuates crescentic disease. BALB/c mice, which are
Th2 prone, also develop severe renal injury [4]. However, their
disease is characterized not by crescent formation but by glomer-
ular deposition of autologous antibody and complement, absence
of skin DTH to SG, and higher levels of splenic T cell IL-4
production relative to IFN-g.
Interleukin-4 is a critical cytokine in determining the pattern of
cytokine secretion of primed CD41 T cells. Interleukin-4 facili-
tates development of a Th2 phenotype and inhibits IFN-g pro-
duction by activated T cells in vitro [10]. However, IL-12 has the
opposite effect [20]. These observations are supported by analyses
of the immune responses of mice genetically deficient in IL-4 to
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Fig. 1. Histological injury in IL-41/1 and IL-42/2 mice with glomerulonephritis. Photomicrographs of glomeruli from IL-41/1 mice with GN show
proliferative GN at low power (A, silver methenamine/acid fuchsin stain, 3100) and high power (C, 3400), with CD41 T cell infiltration (E,
immunoperoxidase with hematoxylin counterstain using GK1.5, 3400) and macrophage accumulation (G, immunoperoxidase using M1/70, 3400). Mice
deficient in IL-4 develop markedly more severe disease with frequent glomerular crescent formation (B, 3100 and D, 3250), and increased T cells (F,
3250) and macrophages (H, 3400).
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parasitic infection, [12, 21] showing decreased production of other
Th2 cytokines, including IL-10 and IL-13, and increased IFN-g
levels. Serum IgG1 is reduced and IgG2a, IgG2b and IgG3 are
increased [21]. Therefore, IL-4 is an important determinant of the
nature of the effector immune response. Furthermore, in genet-
ically normal mice, IL-12 profoundly up-regulates antigen specific
IgG2a, IgG2b and IgG3 production [22].
The current studies were performed to address the hypothesis
that endogenously produced IL-4 is protective in the context of a
Th1 directed, non-infective inflammatory immune response. It
was hypothesized that in crescentic GN, IL-4 (and thus the Th2
element of the immune response) prevents extreme polarization
of the immune response to a Th1 profile. Therefore, deficiency of
IL-4 would enhance Th1 responses to a nephritogenic antigen.
This would lead to increased crescent formation and renal injury.
Fig. 2. Features of glomerular disease in IL-41/1 and IL-42/2 mice
with glomerulonephris. Interleukin-4 deficiency markedly exacerbated
GN with more frequent glomerular crescents, increased glomerular fibrin
deposition and increased numbers of macrophages and CD41 T cells in
glomeruli of diseased IL-42/2 mice indicating enhanced features of DTH
in glomeruli. Abbreviation c/gcs is cells per glomerular cross section.
Table 1. Deposition of murine IgG isotypes in glomeruli of IL-41/1
and IL-42/2 mice 10 days after initiation of glomerulonephritis
IL-41/1 IL-42/2
IgG1 21 1
IgG2a 1 1
IgG2b 1 31
IgG3 1 21
Changes in the glomerular deposition of immunoglobulin isotypes were
evaluated by semiquantitative scoring of fluorescence intensity (0 to 31),
at an antibody dilution of 1 in 100.
Table 2. Sheep globulin specific IgG isotypes in sera of IL-41/1 and
IL-42/2 mice 10 days after initiation of glomerulonephritis
IgG1 IgG2a IgG2b IgG3
IL-41/1 1.137 6 0.046 0.352 6 0.100 0.176 6 0.027 0.057 6 0.010
IL-42/2 0.641 6 0.042a 0.256 6 0.034 1.414 6 0.053a 0.326 6 0.073a
Normal
mouse
serum
0.001 6 0.001 0.012 6 0.004 0.022 6 0.004 0.014 6 0.007
Sera at a dilution of 1 in 200 were assessed by ELISA. Results are
expressed as the mean OD405 6 SEM.
a P , 0.002 vs. IL-41/1 mice.
Fig. 3. Proteinuria in IL-41/1 (l) and IL-42/2 (f) mice with glomer-
ulonephritis. All nephritic mice developed proteinuria. IL-42/2 mice
developed more severe proteinuria compared to IL-41/1 mice early in
the disease.
Kitching et al: IL-4 deficiency promotes crescent formation116
To address this question, immune responses and renal injury were
studied in mice genetically deficient in IL-4 using a model of
crescentic GN. Glomerulonephritis was induced by planting an
antigen, sheep globulin, into kidneys of sensitized mice. Geneti-
cally normal mice developed proliferative GN with occasional
crescent formation, associated with glomerular T cell and macro-
phage infiltration and glomerular fibrin deposition. These histo-
logical changes were accompanied by proteinuria and renal
impairment. Mice developed skin DTH in response to cutaneous
antigen challenge. IL-42/2 mice developed increased Th1 re-
sponses to SG, as evidenced by increased skin DTH, a trend to
increased splenic T cell IFN-g production, and increased serum
IgG2b and IgG3. The decrease in antigen specific serum IgG1
levels confirms the decreased Th2 responsiveness of IL-4 deficient
mice previously demonstrated [12, 23]. Glomerulonephritis in
IL-42/2 mice was exacerbated, with markedly increased crescent
formation, and increases in glomerular T cells, macrophages and
fibrin deposition, features that occur in the setting of DTH.
Changes in the deposition of glomerular immunoglobulin isotypes
reflected the alterations observed in serum antigen specific im-
munoglobulin levels.
The lower level of crescent formation found in IL-41/1 mice
in this study compared to that seen previously in pure C57BL/6
mice [19] may reflect a strain difference between pure C57BL/6
mice and the C57BL/6 3 129Sv mice used in these studies.
However, an alternative explanation is that the dose of anti-
GBM globulin used was intentionally lower than that used in a
previous study (in C57BL/6 mice) that employed the same
batch of antibody [19].
The lack of an increase in antigen-specific IgG2a response in
IL-42/2 mice compared to IL-41/1 mice does not fit this
pattern, but has been observed in previous studies of immune
responses in IL-4 deficient mice [21, 24]. Autologous antibody
production is not required for crescent formation in this model
[17]. Therefore, the changes in immunoglobulin isotype levels in
this study are unlikely to be of pathogenetic significance in
themselves and can be considered as markers of a shift in the T
helper cell response to the nephritogenic antigen. The results of
this study, when taken in the context of previous work in both
human [16] and experimental [17, 18] crescentic GN, suggest that
it is the Th1 derived, cell mediated component of the nephrito-
genic immune response that is critical in the pathogenesis of
glomerular crescent formation.
In addition to the shift in the Th1/Th2 balance, other mecha-
nisms may have contributed to the exacerbation of GN in
IL-42/2 mice. Interleukin-4 has been shown to directly deacti-
vate macrophages in vitro [25–27] and to prevent induction of
tissue factor mRNA in stimulated human monocytes [28]. There is
evidence that IL-4 promotes synthesis of intrarenal 15-lipoxygen-
ase [29], and it is possible that reduced glomeruloprotective
prostanoid synthesis may have had deleterious hemodynamic
consequences contributing to the increased renal impairment
observed in IL-42/2 mice with GN.
In summary, genetic deficiency of IL-4, and therefore of
endogenous Th2 responses, increases Th1-mediated renal injury,
with increased glomerular cell mediated immunity (that is, fea-
tures of DTH) and evidence of a shift in the systemic immune
response to the nephritogenic antigen further towards a Th1
response. These studies demonstrate that endogenous IL-4 is
protective in the context of crescentic GN, an injurious Th1
response to antigens in glomeruli.
Fig. 5. The effect of IL-4 gene deletion on the DTH response to cutaneous
antigen challenge and antigen stimulated production of IFN-g by splenic
T lymphocytes from mice with glomerulonephritis. Cutaneous DTH was
increased in IL-42/2 mice compared to genetically intact mice. There was
a trend to increased production of IFN-g by splenic T cells isolated from
nephritic IL-4 deficient mice that did not reach statistical significance (P 5
0.096).
Fig. 4. Renal function in diseased IL-41/1 and IL-42/2 mice (day 10 of
disease), with normal mice for comparison. Interleukin-4 deficient mice
developed severe renal failure compared to IL-41/1 animals.
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APPENDIX
Abbreviations used in this article are: IL, interleukin; GN, glomerulo-
nephritis; Th, T helper cell; DTH, delayed-type hypersensitivity; SG,
sheep globulin; GBM, glomerular basement membrane; OCT, optimal
cutting temperature compound; IFN-g, interferon-g; c/gcs, cells per
glomerular cross section.
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